Drug Shortage Report for TEVA-VENLAFAXINE XR

Last updated on 2019-11-08 History
Report ID 92672
Drug Identification Number 02275058
Brand name TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE
Company Name TEVA CANADA LIMITED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-28
Estimated end date 2019-12-31
Actual end date 2019-11-07
Shortage status Resolved
Updated date 2019-11-08
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-11-08 English Compare
v10 2019-11-07 French Compare
v9 2019-11-07 English Compare
v8 2019-10-24 French Compare
v7 2019-10-24 English Compare
v6 2019-10-24 French Compare
v5 2019-10-24 English Compare
v4 2019-10-03 French Compare
v3 2019-10-03 English Compare
v2 2019-08-29 French Compare
v1 2019-08-29 English Compare